TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

Evaxion Reveals Novel AI-Immunology™-Based Strategy for Precision Cancer Vaccines, Potentially Paving the Way for a Breakthrough

Thursday, November 30, 2023

Evaxion Biotech A/S (NASDAQ: EVAX) is thrilled to present its innovative precision vaccine concept at the upcoming 65th Annual Meeting of the American Society of Hematology (ASH) from December 9-12, 2023, in San Diego, California.

The company, a clinical-stage TechBio firm specializing in AI-Immunology™-powered vaccine development, has been selected for an oral presentation after a rigorous selection process that considered over 5000 submitted abstracts. During the presentation, Evaxion will highlight a groundbreaking innovation utilizing its in-house AI target discovery and development platform, AI-Immunology™. This unique approach incorporates endogenous retroviruses (ERVs), an exclusive source of target molecules, along with data-driven insights, resulting in a novel concept for precision vaccines tailored specifically for hematological malignancies and select solid cancers.

These precision vaccines, customized to match the specific tumor profiles and immune systems of different patient groups, represent a notable advancement in the treatment of complex cancers, including hematologic malignancies. Evaxion's research results open up new possibilities for broader applications of vaccines in cancer therapy.

The emphasis on ERVs, remnants of ancient viruses integrated into the human genome, adds a distinct dimension to Evaxion's approach. While dormant in normal cells due to stringent epigenetic control mechanisms, cancer cells can express these ERVs, making them an ideal target for cancer vaccines. This novel strategy holds promise for reshaping the landscape of cancer treatment and expanding the potential of vaccine-based therapies.



patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit